Update of the drug resistance mutations in HIV-1: Fall 2006.

Victoria A Johnson, Francoise Brun-Vezinet, Bonaventura Clotet, Daniel R Kuritzkes, Deenan Pillay, Jonathan M Schapiro, Douglas D Richman
{"title":"Update of the drug resistance mutations in HIV-1: Fall 2006.","authors":"Victoria A Johnson,&nbsp;Francoise Brun-Vezinet,&nbsp;Bonaventura Clotet,&nbsp;Daniel R Kuritzkes,&nbsp;Deenan Pillay,&nbsp;Jonathan M Schapiro,&nbsp;Douglas D Richman","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The International AIDS Society-USA (IAS-USA) Drug Resistance Mutations Group is marking 6 years as an independent volunteer panel of experts focused on identifying key HIV-1 drug resistance mutations. The goal of the effort is to quickly deliver accurate and unbiased information on these mutations to HIV clinical practitioners. This version of the IAS-USA Drug Resistance Mutations Figures replaces the version published in this journal in October/November 2005. The IAS-USA Drug Resistance Mutations Figures are designed for use in identifying mutations associated with viral resistance to antiretroviral drugs and in making therapeutic decisions. Care should be taken when using this list of mutations for surveillance or epidemiologic studies of transmission of drug-resistant virus. A number of amino acid substitutions, particularly minor mutations, represent polymorphisms that in isolation may not reflect prior drug selective pressure or reduced drug susceptibility.</p>","PeriodicalId":85800,"journal":{"name":"Topics in HIV medicine : a publication of the International AIDS Society, USA","volume":"14 3","pages":"125-30"},"PeriodicalIF":0.0000,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Topics in HIV medicine : a publication of the International AIDS Society, USA","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The International AIDS Society-USA (IAS-USA) Drug Resistance Mutations Group is marking 6 years as an independent volunteer panel of experts focused on identifying key HIV-1 drug resistance mutations. The goal of the effort is to quickly deliver accurate and unbiased information on these mutations to HIV clinical practitioners. This version of the IAS-USA Drug Resistance Mutations Figures replaces the version published in this journal in October/November 2005. The IAS-USA Drug Resistance Mutations Figures are designed for use in identifying mutations associated with viral resistance to antiretroviral drugs and in making therapeutic decisions. Care should be taken when using this list of mutations for surveillance or epidemiologic studies of transmission of drug-resistant virus. A number of amino acid substitutions, particularly minor mutations, represent polymorphisms that in isolation may not reflect prior drug selective pressure or reduced drug susceptibility.

HIV-1耐药突变的最新进展:2006年秋季。
美国国际艾滋病协会(IAS-USA)耐药突变小组成立6周年,该小组是一个由专家组成的独立志愿者小组,专注于确定关键的HIV-1耐药突变。这项工作的目标是迅速向艾滋病毒临床从业人员提供有关这些突变的准确和公正的信息。此版本的IAS-USA耐药突变数据取代了2005年10月/ 11月在本刊上发表的版本。IAS-USA耐药突变图旨在用于识别与病毒对抗逆转录病毒药物耐药性相关的突变,并用于制定治疗决策。在使用该突变清单进行耐药病毒传播的监测或流行病学研究时应谨慎。一些氨基酸取代,特别是微小的突变,代表了多态性,这些多态性单独可能不能反映先前的药物选择压力或降低的药物敏感性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书